Get started
Maravai LifeSciences Holdings, Inc.Maravai LifeSciences Holdings, Inc.Maravai LifeSciences Holdings, Inc.

Maravai LifeSciences Holdings, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

MRVI chart


Full chart

MRVI upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.22 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.65 USD
Net income (FY)
‪−119.03 M‬ USD
Revenue (FY)
‪288.94 M‬ USD
Shares float
‪117.53 M‬
Beta (1Y)
1.10

Employees


Employees (FY)
650
Change (1Y)
+40 +6.56%
Revenue / Employee (1Y)
‪444.53 K‬ USD
Net income / Employee (1Y)
‪−183.12 K‬ USD

About Maravai LifeSciences Holdings, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
William Martin
Website
maravai.com
Headquarters
San Diego
Founded
2014
FIGI
BBG00Y1DFV91
Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

MRVI news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MRVI is 4.82 USD — it has increased by 4.10% in the past 24 hours. Watch Maravai LifeSciences Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Maravai LifeSciences Holdings, Inc. stocks are traded under the ticker MRVI.
MRVI stock has fallen by −23.73% compared to the previous week, the month change is a −42.28% fall, over the last year Maravai LifeSciences Holdings, Inc. has showed a −2.63% decrease.
We've gathered analysts' opinions on Maravai LifeSciences Holdings, Inc. future price: according to them, MRVI price has a max estimate of 13.00 USD and a min estimate of 7.00 USD. Watch MRVI chart and read a more detailed Maravai LifeSciences Holdings, Inc. stock forecast: see what analysts think of Maravai LifeSciences Holdings, Inc. and suggest that you do with its stocks.
MRVI reached its all-time high on Aug 23, 2021 with the price of 63.55 USD, and its all-time low was 4.39 USD and was reached on Nov 15, 2024. View more price dynamics on MRVI chart.
See other stocks reaching their highest and lowest prices.
MRVI stock is 9.42% volatile and has beta coefficient of 1.10. Track Maravai LifeSciences Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is Maravai LifeSciences Holdings, Inc. there?
Today Maravai LifeSciences Holdings, Inc. has the market capitalization of ‪683.69 M‬, it has decreased by −17.76% over the last week.
Yes, you can track Maravai LifeSciences Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
Maravai LifeSciences Holdings, Inc. is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
MRVI earnings for the last quarter are −0.02 USD per share, whereas the estimation was −0.01 USD resulting in a −139.15% surprise. The estimated earnings for the next quarter are −0.04 USD per share. See more details about Maravai LifeSciences Holdings, Inc. earnings.
Maravai LifeSciences Holdings, Inc. revenue for the last quarter amounts to ‪65.20 M‬ USD, despite the estimated figure of ‪67.55 M‬ USD. In the next quarter, revenue is expected to reach ‪56.65 M‬ USD.
MRVI net income for the last quarter is ‪−99.04 M‬ USD, while the quarter before that showed ‪−7.58 M‬ USD of net income which accounts for ‪−1.21 K‬% change. Track more Maravai LifeSciences Holdings, Inc. financial stats to get the full picture.
No, MRVI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 650.00 employees. See our rating of the largest employees — is Maravai LifeSciences Holdings, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Maravai LifeSciences Holdings, Inc. EBITDA is ‪14.17 M‬ USD, and current EBITDA margin is 15.43%. See more stats in Maravai LifeSciences Holdings, Inc. financial statements.
Like other stocks, MRVI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Maravai LifeSciences Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Maravai LifeSciences Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Maravai LifeSciences Holdings, Inc. stock shows the sell signal. See more of Maravai LifeSciences Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.